Pooja Shah - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pooja Shah

Showing results (131-140 of 133) with videos related to

Pageof 14

Sort By:

You have reached the last page of results.This site can display upto 133 results.

Nature Chemical Biology|September 12, 2017

Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026

A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial CancerMaria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.

Science Translational Medicine|September 15, 2021

A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S Lightcap, Pengfei Yu, Stephen Grossman, et al.

Pageof 14

Search research articles

Showing results (131-140 of 133) with videos related to

Sort By:

Pageof 14

You have reached the last page of results.This site can display upto 133 results.

Nature Chemical Biology|September 12, 2017

Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2026

A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial CancerMaria M Rubinstein, Jennifer Y Ge, Qin Zhou, et al.

Science Translational Medicine|September 15, 2021

A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S Lightcap, Pengfei Yu, Stephen Grossman, et al.

Pageof 14